These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7920019

  • 1. Lodoxamide treatment of allergic conjunctivitis.
    Cerqueti PM, Ricca V, Tosca MA, Buscaglia S, Ciprandi G.
    Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H, Bitiren M, Aslan OS, Ozardali I.
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [Abstract] [Full Text] [Related]

  • 3. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G.
    Allergol Immunopathol (Madr); 1997 Jun; 25(5):233-7. PubMed ID: 9395007
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, Bucci MG.
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [Abstract] [Full Text] [Related]

  • 5. Antiallergic activity of topical lodoxamide on in vivo and in vitro models.
    Ciprandi G, Buscaglia S, Catrullo A, Paolieri F, Riccio AM, Fiorino N, Canonica GW.
    Allergy; 1996 Dec; 51(12):946-51. PubMed ID: 9020426
    [Abstract] [Full Text] [Related]

  • 6. Clobetasone treatment of allergic conjunctivitis: a comparative double blind study.
    Cerqueti PM, Prosio PE, Bosia S, Buscaglia S, Ciprandi G.
    Allergol Immunopathol (Madr); 1993 Dec; 21(2):67-70. PubMed ID: 8337991
    [Abstract] [Full Text] [Related]

  • 7. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M.
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [Abstract] [Full Text] [Related]

  • 8. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C, Trinquand C, Bloch-Michel E.
    Eur J Ophthalmol; 1998 Oct; 8(4):207-16. PubMed ID: 9891891
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I, Gabrić N, Lazić R, Bosnar D, Cima I, Stipić A.
    Acta Med Croatica; 2002 Oct; 56(3):93-8. PubMed ID: 12630339
    [Abstract] [Full Text] [Related]

  • 10. Lodoxamide in vernal keratoconjunctivitis.
    Lee S, Allard TR.
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
    Gündüz K, Uçakhan O, Budak K, Eryilmaz T, Ozkan M.
    Ophthalmic Res; 1996 May; 28(2):80-7. PubMed ID: 8792357
    [Abstract] [Full Text] [Related]

  • 12. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO, Onakoya AO, Olasimbo OO, Adefule AK.
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [Abstract] [Full Text] [Related]

  • 13. Topical anti-inflammatory drugs in the treatment of allergic pollinosic conjunctivitis: a comparative double-blind study.
    Ciprandi G, Buscaglia S, Cerqueti MP, Saccà S, Tosca M, Canonica GW.
    J Investig Allergol Clin Immunol; 1992 Mar; 2(5):248-52. PubMed ID: 1342906
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S.
    Oftalmologia; 2001 Mar; 52(2):81-4. PubMed ID: 11771108
    [Abstract] [Full Text] [Related]

  • 15. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT, Easty DL, Collum LM, Benedict-Smith A, Hillery M, Parsons DG.
    Eur J Ophthalmol; 1992 Mar; 2(3):144-9. PubMed ID: 1450659
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D, Khan M, Gul A, Alam R.
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [Abstract] [Full Text] [Related]

  • 17. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J.
    Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
    [Abstract] [Full Text] [Related]

  • 18. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P, Allewaert R, Joyaux JC, Piozzi E, Koliopoulos J, Bloch-Michel E, Lodoxamide Study Group.
    Eur J Ophthalmol; 2001 Jan; 11(2):120-5. PubMed ID: 11456011
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR, Verin P, Hartwich-Young R, Meyer SM, Drake MM.
    Am J Ophthalmol; 1992 Jun 15; 113(6):632-7. PubMed ID: 1598953
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM, Avunduk MC, Kapicioglu Z, Akyol N, Tavli L.
    Ophthalmology; 2000 Jul 15; 107(7):1333-7. PubMed ID: 10890862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.